BRTX CIK: 1505497

BioRestorative Therapies, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
21.5
FY22:
15.1
FY23:
11.4
FY24:
11.1
FY25:
3.14
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.99
FY22:
1.31
FY23:
1.22
FY24:
1.14
FY25:
0.94
Total assets
Change from FY21 to FY25
millions USD
FY21:
22.5
FY22:
16.4
FY23:
12.6
FY24:
12.3
FY25:
4.08

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
0.36
FY22:
5.98
FY23:
2.61
FY24:
3.75
FY25:
3.72
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.49
FY22:
0.16
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
21.6
FY22:
10.3
FY23:
10.0
FY24:
8.53
FY25:
0.36
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
22.5
FY22:
16.4
FY23:
12.6
FY24:
12.3
FY25:
4.08

All amounts in millions USD Data sources:SEC EDGARTwelve Data